34 related articles for article (PubMed ID: 8738464)
1. Topical tacrolimus in high-risk corneal transplants.
Bernardes L; Gil J; Costa E; Tavares C; Rosa A; Quadrado MJ; Murta J
Eur J Ophthalmol; 2024 Jan; 34(1):140-145. PubMed ID: 37128645
[TBL] [Abstract][Full Text] [Related]
2. The pharmacodynamics of pentobarbital following FK 506 therapy.
Habucky K; Venkataramanan R; Xiaoshan R; Warty VS; Fung JJ; Starzl TE
Transplant Proc; 1991 Dec; 23(6):2800-1. PubMed ID: 1721282
[No Abstract] [Full Text] [Related]
3. Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection.
Wu Q; Liu D; Zhang X; Wang D; DongYe M; Chen W; Lin D; Zhu F; Chen W; Lin H
Drug Deliv; 2019 Dec; 26(1):290-299. PubMed ID: 30895841
[TBL] [Abstract][Full Text] [Related]
4. Aqueous humor and serum penetration of tacrolimus after topical and oral administration in rats: an absorption study.
Yalçindağ FN; Batioğlu F; Ari N; Ozdemir O
Clin Ophthalmol; 2007 Mar; 1(1):61-4. PubMed ID: 19668467
[TBL] [Abstract][Full Text] [Related]
5. Short-term Efficacy of Topical Immunosuppressive Agents on the Survival of Cultivated Allo-Conjunctival Equivalents.
Shin YJ; Kim MK; Oh JY; Wee WR; Lee JH; Ko JH; Lee HJ; Lee JL; Min BM; Sohn YS
Korean J Ophthalmol; 2008 Jun; 22(2):123-9. PubMed ID: 18612231
[TBL] [Abstract][Full Text] [Related]
6. [Topical immunosuppressives after penetrating keratoplasty].
Birnbaum F; Reis A; Reinhard T
Ophthalmologe; 2007 May; 104(5):381-7. PubMed ID: 17387481
[TBL] [Abstract][Full Text] [Related]
7. [Immunomodulation in penetrating keratoplasty. Current status and perspectives].
Pleyer U
Ophthalmologe; 2003 Dec; 100(12):1036-44. PubMed ID: 14704816
[TBL] [Abstract][Full Text] [Related]
8. [Systemic immunosuppressives after penetrating keratoplasty].
Reis A; Birnbaum F; Reinhard T
Ophthalmologe; 2007 May; 104(5):373-80. PubMed ID: 17387480
[TBL] [Abstract][Full Text] [Related]
9. Immune mechanisms of corneal allograft rejection.
Niederkorn JY
Curr Eye Res; 2007 Dec; 32(12):1005-16. PubMed ID: 18085464
[TBL] [Abstract][Full Text] [Related]
10. Effect of FK 506 administered topically versus intramuscularly on suppression of the corneal immune reaction in rats.
Okada K; Sakata H; Minamoto A; Fujihara M
Ophthalmologica; 1996; 210(3):175-9. PubMed ID: 8738464
[TBL] [Abstract][Full Text] [Related]
11. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
[TBL] [Abstract][Full Text] [Related]
12. Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty.
Minamoto A; Sakata H; Okada K; Fujihara M
Jpn J Ophthalmol; 1995; 39(1):12-9. PubMed ID: 7543958
[TBL] [Abstract][Full Text] [Related]
13. Effect of FK 506 on the cornea: use of topical FK 506 in corneal transplantation in a guinea pig-rat model.
Tchah H; Lim B
Korean J Ophthalmol; 1999 Dec; 13(2):71-7. PubMed ID: 10761401
[TBL] [Abstract][Full Text] [Related]
14. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
[TBL] [Abstract][Full Text] [Related]
15. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats].
Lü L; Zhang W; Sun X
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):25-8. PubMed ID: 11835769
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
